How should trazodone-induced hyponatremia be managed?

Management of Trazodone-Induced Hyponatremia

Discontinue trazodone immediately in patients with symptomatic hyponatremia and institute appropriate medical intervention based on symptom severity, as trazodone-induced hyponatremia typically results from SIADH and requires drug cessation as the primary intervention. 1

Initial Assessment and Drug Discontinuation

• Stop trazodone immediately when hyponatremia is identified, as the FDA label explicitly states to "discontinue Trazodone Hydrochloride Tablets and institute appropriate medical intervention" in patients with symptomatic hyponatremia 1
• Recognize that trazodone causes hyponatremia through SIADH (syndrome of inappropriate antidiuretic hormone secretion), with cases documented showing serum sodium levels below 110 mmol/L 1
• Be aware that elderly patients, those taking diuretics, and volume-depleted patients face greater risk 1

Symptom-Based Treatment Algorithm

Severe Symptoms (Mental Status Changes, Seizures, Coma)

• Transfer to ICU with Q2-hour sodium monitoring 2
• Administer 3% hypertonic saline to correct 6 mEq/L over 6 hours or until severe symptoms resolve 2
• Do not exceed 8 mEq/L total correction in 24 hours - if 6 mEq/L corrected in first 6 hours, limit additional correction to 2 mEq/L over the following 18 hours 2
• Calculate sodium deficit using: Desired increase in Na (mEq) × (0.5 × ideal body weight in kg) 2
• Monitor for cerebral edema, as fatal cases have been reported with trazodone overdose presenting with seizures and hyponatremia 3

Mild Symptoms (Nausea, Vomiting, Headache, Confusion, Weakness) or Na <120 mmol/L

• Transfer to intermediate care unit with Q4-hour sodium monitoring 2
• Implement fluid restriction to 1 L/day as the cornerstone of SIADH treatment 2
• Add oral sodium chloride 100 mEq TID if no response to fluid restriction 2
• Consider high-protein diet to increase solute load 2

Asymptomatic or Mild Hyponatremia

• Fluid restriction 1 L/day 2
• Daily sodium monitoring 2
• Oral sodium supplementation if needed 2

Critical Pitfalls to Avoid

Do not use fluid restriction in volume-depleted patients, as this can worsen outcomes - ensure adequate volume assessment before implementing fluid restriction 2

Avoid rapid overcorrection in chronic hyponatremia (>48 hours duration), as correction rates exceeding 1 mmol/L/hour risk osmotic demyelination syndrome 2. Rapid correction should be reserved only for acute hyponatremia (<48 hours) with severe symptoms 2

Monitor for falls and neurological complications, as hyponatremia symptoms include unsteadiness, confusion, and in severe cases can progress to hallucinations, syncope, seizures, respiratory arrest, and death 1

Monitoring After Drug Discontinuation

• Continue sodium monitoring until levels stabilize above 131 mmol/L 2
• Reassess volume status, as many cases resolve with drug cessation alone 4, 5
• Consider alternative antidepressant if continued treatment needed - bupropion shows lower hyponatremia risk compared to other antidepressants 6
• Screen for other contributing medications (diuretics, SSRIs, anticonvulsants) that may compound hyponatremia risk 7, 8, 5

Special Considerations

Trazodone-induced hyponatremia typically develops through SIADH mechanisms, though some evidence suggests possible nephrogenic syndrome of inappropriate antidiuresis (NSIAD) with intrarenal AQP2 upregulation 4. Regardless of mechanism, drug discontinuation remains the primary intervention, with supportive treatment guided by symptom severity and chronicity of hyponatremia 1, 9.